Aug 16, 2017 11:51 pm EDT Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM
Jul 28, 2017 8:15 am EDT Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures
May 18, 2017 8:00 am EDT Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions
Apr 24, 2017 8:00 am EDT Acasti Granted Additional Composition & Use Patents in Taiwan and Australia; Safeguards Valuable Market Expansion Opportunities